Advances in chemotherapy for head and neck cancer

Oral Oncology

Volumn 46, Issue 6, 2010, Pages 436-438

  Bhide, S A ^a   Nutting, C M ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Chemotherapy; Neck cancer

Indexed keywords

CARBOPLATIN; CETUXIMAB; CISPLATIN; DOCETAXEL; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; FLUOROURACIL; MITOMYCIN C; PACLITAXEL; PANITUMUMAB; SODIUM THIOSULFATE;

ACNE; ADVANCED CANCER; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; CONCOMITANT CHEMOTHERAPY; DNA DAMAGE; DRUG MEGADOSE; DRUG TOLERABILITY; DYSPHAGIA; HEAD AND NECK CANCER; HEAD AND NECK CARCINOMA; HUMAN; INDUCTION CHEMOTHERAPY; LOW DRUG DOSE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; REVIEW; SKIN TOXICITY; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME;

ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS AS TOPIC; EVIDENCE-BASED MEDICINE; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; REMISSION INDUCTION;

EID: 77952745968     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2010.03.004     Document Type: Review

References (36)

1. Pignon J.P., et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 355 9208 (2000) 949-955
2. Lefebvre J.L. Laryngeal preservation in head and neck cancer: multidisciplinary approach. Lancet Oncol 7 9 (2006) 747-755
3. Wilson G.D., Bentzen S.M., and Harari P.M. Biologic basis for combining drugs with radiation. Semin Radiat Oncol 16 1 (2006) 2-9
4. Adelstein D.J., et al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 21 1 (2003) 92-98
5. Forastiere A.A., et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349 22 (2003) 2091-2098
6. Bhide S.A., et al. Sequential induction chemotherapy followed by radical chemo-radiation in the treatment of locoregionally advanced head-and-neck cancer. Br J Cancer 99 1 (2008) 57-62
7. Jeremic B., et al. Radiation therapy with or without concurrent low-dose daily chemotherapy in locally advanced, nonmetastatic squamous cell carcinoma of the head and neck. J Clin Oncol 22 17 (2004) 3540-3548
8. Madhava K., et al. Carboplatin and hypofractionated accelerated radiotherapy: a dose escalation study of an outpatient chemoradiation schedule for squamous cell carcinoma of the head and neck. Clin Oncol (R Coll Radiol) 18 1 (2006) 77-81
9. Agarwala S.S., et al. Long-term outcomes with concurrent carboplatin, paclitaxel and radiation therapy for locally advanced, inoperable head and neck cancer. Ann Oncol 18 7 (2007) 1224-1229
10. Suntharalingam M., et al. The use of carboplatin and paclitaxel with daily radiotherapy in patients with locally advanced squamous cell carcinomas of the head and neck. Int J Radiat Oncol Biol Phys 47 1 (2000) 49-56
11. Budach V., et al. Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial. J Clin Oncol 23 6 (2005) 1125-1135
12. Calais G., et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 91 24 (1999) 2081-2086
13. Robbins K.T., et al. Supradose intra-arterial cisplatin and concurrent radiation therapy for the treatment of stage IV head and neck squamous cell carcinoma is feasible and efficacious in a multi-institutional setting: results of Radiation Therapy Oncology Group Trial 9615. J Clin Oncol 23 7 (2005) 1447-1454
14. Bernier J., et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (#9501). Head Neck 27 10 (2005) 843-850
15. Monnerat C., et al. End points for new agents in induction chemotherapy for locally advanced head and neck cancers. Ann Oncol 13 7 (2002) 995-1006
16. Lefebvre J.L., et al. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 88 13 (1996) 890-899
17. Paccagnella A., et al. Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo. J Natl Cancer Inst 86 4 (1994) 265-272
18. Robbins K.T., et al. Standardizing neck dissection terminology. Official report of the Academy's Committee for Head and Neck Surgery and Oncology. Arch Otolaryngol Head Neck Surg 117 6 (1991) 601-605
19. Zorat P.L., et al. Randomized phase III trial of neoadjuvant chemotherapy in head and neck cancer: 10-year follow-up. J Natl Cancer Inst 96 22 (2004) 1714-1717
20. Hitt R., et al. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer. J Clin Oncol 23 34 (2005) 8636-8645
21. Posner M.R., et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 357 17 (2007) 1705-1715
22. Vermorken J.B., et al. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 357 17 (2007) 1695-1704
23. Bradley J.D., et al. Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: promising long-term results of the Radiation Therapy Oncology Group-RTOG 9705. J Clin Oncol 23 15 (2005) 3480-3487
24. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med 1991;324(24):1685-90.
25. Cohen E.E., Lingen M.W., and Vokes E.E. The expanding role of systemic therapy in head and neck cancer. J Clin Oncol 22 9 (2004) 1743-1752
26. Ang K.K., et al. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res 62 24 (2002) 7350-7356
27. Bonner J.A., et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354 6 (2006) 567-578
28. Bonner J.A., et al. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol 11 (2010) 21-28
29. Giro C., et al. High rate of severe radiation dermatitis during radiation therapy with concurrent cetuximab in head and neck cancer: results of a survey in EORTC institutes. Radiother Oncol 90 2 (2009) 166-171
30. Pryor D.I., et al. Enhanced toxicity with concurrent cetuximab and radiotherapy in head and neck cancer. Radiother Oncol 90 2 (2009) 172-176
31. Harrington K.J. Rash conclusions from a phase 3 study of cetuximab?. Lancet Oncol 11 1 (2010) 2-3
32. Harrington K.J., et al. Phase I study of lapatinib in combination with chemoradiation in patients with locally advanced squamous cell carcinoma of the head and neck. J Clin Oncol 27 7 (2009) 1100-1107
33. Rivera F., et al. Cetuximab in metastatic or recurrent head and neck cancer: the EXTREME trial. Expert Rev Anticancer Ther 9 10 (2009) 1421-1428
34. Wirth L.J., et al. Phase I dose-finding study of paclitaxel with panitumumab, carboplatin and intensity-modulated radiotherapy in patients with locally advanced squamous cell cancer of the head and neck. Ann Oncol 21 (2010) 342-347
35. Kies M.S., et al. Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial. J Clin Oncol 28 1 (2010) 8-14
36. Haddad R.I., et al. Phase I study of C-TPF in patients with locally advanced squamous cell carcinoma of the head and neck. J Clin Oncol 27 27 (2009) 4448-4453